Past, present, and future of insulin pump therapy: better shot at diabetes control
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
With the advent of continuous subcutaneous insulin infusion therapy and the findings of the Diabetes Control and Complications Trial, the management of type 1 diabetes has changed drastically. Over the past 30 years since its development, the effectiveness of continuous subcutaneous insulin infusion has been assessed in comparison with other modes of intensive treatment. Additionally, improvements in pump delivery systems have been made. Here, the findings of the studies on pump therapy are reviewed. Selection criteria of patients for pump use and how to initiate pump therapy are presented. Finally, newer findings on continuous glucose sensors are discussed as the next era of pump therapy continues to focus on the goal of developing an artificial pancreas. Mt Sinai J Med 75:352–361, 2008. © 2008 Mount Sinai School of Medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2142 · Cited by 818
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
Amiel, S. A., Sherwin, R. S., Simonson, D. C., & Tamborlane, W. V. (1988) · Diabetes · doi:10.2337/diab.37.7.901 · Cited by 393
Self-citationDoyle (Boland), E. A., Weinzimer, S. A., Steffen, A. T., Ahern, J. A. H., Vincent, M., & Tamborlane, W. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1554 · Cited by 373
Self-citationAmiel, S. A., Tamborlane, W. V., Simonson, D. C., & Sherwin, R. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162205 · Cited by 309 · cited 1×
“An increased risk of severe hypoglycemia, due in part to reductions in counterregulatory hormone responses to hypoglycemia, was demonstrated (5,6).”
BackgroundSelf-citationBurdick, J., Chase, H. P., Slover, R. H., Knievel, K., Scrimgeour, L., Maniatis, A. K., & Klingensmith, G. J. (2004) · Pediatrics · doi:10.1542/peds.113.3.e221 · Cited by 227
Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes
Plotnick, L. P., Clark, L. M., Brancati, F. L., & Erlinger, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1142 · Cited by 216 · cited 1×
“9% (12-25), the frequency of clinically important hypoglycemia was reduced (12-19,21-25) and BMI z-scores did not increase (12-16,18,20-25).”
BackgroundOpipari-Arrigan, L., Fredericks, E. M., Burkhart, N., Dale, L., Hodge, M., & Foster, C. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00283.x · Cited by 64 · cited 1×
“CSII (35-38) but the majority of these studies were in very young children where target glucose levels were set considerably higher than in older children and adolescents.”
BackgroundAlemzadeh, R., Ellis, J. N., Holzum, M. K., Parton, E. A., & Wyatt, D. T. (2004) · Pediatrics · doi:10.1542/peds.114.1.e91 · Cited by 63
Cited by
Sleep in type 1 diabetes: implications for glycemic control and diabetes management
Perez, K. M., Hamburger, E. R., Lyttle, M., Williams, R., Bergner, E., Kahanda, S., Cobry, E., & Jaser, S. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0974-8 · Cited by 86
Llewellyn, S., Procter, R., Harvey, G., Maniatopoulos, G., & Boyd, A. (2014) · Health Services and Delivery Research · doi:10.3310/hsdr02230 · Cited by 43
Aleppo, G., DeSalvo, D. J., Lauand, F., Huyett, L. M., Chang, A., Vienneau, T., & Ly, T. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01366-9 · Cited by 19
Metadata
- Authors
- Sherr, J., & Tamborlane, W. V.
- Venue
- Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
- Publisher
- Wiley
- Published
- 2008-08
- Volume
- 75
- Issue
- 4
- Pages
- 352-361
- ISSN
- 0027-2507 (ISSN-L)
- 1931-7581
- OpenAlex
- W1970990884
- Cited by
- 46
- References
- 9
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.